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Abstract
A remarkable amount of information has emerged in the past decade regarding sweet taste physiology. This article reviews these
data,with a particular focus on theelucidation of the sweet taste receptor, its location and actions in taste transduction in themouth,
its nontaste functions in the gastrointestinal tract (e.g., in enteroendocrine cells), and the brain circuitry involved in the sensory
processing of sweet taste. Complications in the use of rodents to model human sweet taste perception and responses are also
considered. In addition, information relating to low-calorie sweeteners (LCS) is discussed in the context of these issues. Particular
consideration is given to the known effects of LCS on enteroendocrine cell function. J. Nutr. 142: 1134S–1141S, 2012.
Introduction
The tasting of sweetness is a complex physiologic event.
Sweetness is 1 of 5 basic taste qualities. It is historically
associated with the mouth (tongue, soft palate), which contains
taste buds, the sensory organs of taste (1). Subpopulations of
sensory cells in the taste bud respond to sweet molecules by
activating local sensory neurons that project to the brain areas
that process and interpret sensory information (e.g., brainstem,
thalamus, cerebral cortex, and amygdala) (1). Recently, knowl-
edge about sweet taste has grown tremendously, thanks in
considerable part to new experimental technologies (e.g.,
molecular biological tools). This article reviews key aspects of
this new information, including discoveries about the sweet
taste receptor, and of brain pathways associated with sweet
taste perception. In addition, this review discusses how low-
calorie sweeteners (LCS)10 and nutritive sweeteners both acti-
vate sweet taste receptors to trigger taste perception in the brain,
as well as the strengths and limitations associated with the use of
rodents as surrogates for humans in the study of sweet taste.
Finally, we discuss the recent discovery of sweet taste receptors
on intestinal enteroendocrine cells, which release paracrine and
endocrine signals that influence glucose homeostasis, along with
the effects of LCS and nutritive sweeteners on the activity of
these cells.
Mechanisms of Sweetener Detection
Sucrose, saccharin, sucralose, cyclamate, aspartame, and thau-
matin all taste sweet to humans. However, the chemical diversity
of these natural and synthetic compounds begs the question:
Why do they all taste sweet? Research during the past decade
has greatly increased our understanding of the molecular,
genetic, and cellular mechanisms of sweetener detection. These
1 Published in a supplement to The Journal of Nutrition. Presented at the
conference Low-Calorie Sweeteners, Appetite and Weight Control: What the
Science Tells Us, held in Washington, DC, April 7–8, 2011. The conference was
sponsored by the Committee on Low-calorie Sweeteners of the International
Life Sciences Institute North America. The views expressed in these papers are
not necessarily those of the supplement coordinator or guest editors. The
supplement coordinator for this supplement was Adam Drewnowski, University
of Washington. Supplement Coordinator disclosures: Adam Drewnowski
received travel reimbursement for participation in the Low-Calorie Sweeteners
Conference. The supplement is the responsibility of the Guest Editor to whom
the Editor of The Journal of Nutrition has delegated supervision of both technical
conformity to the published regulations of The Journal of Nutrition and general
oversight of the scientific merit of each article. The Guest Editor for this
supplement was Sibylle Kranz. Guest Editor disclosure: Sibylle Kranz has
received funding from The Kellogg Company to conduct research projects
unrelated to this supplement material. She has also been an invited speaker at a
roundtable discussion funded by The Kellogg Company. Publication costs for this
supplement were defrayed in part by the payment of page charges. This
publication must therefore be hereby marked “advertisement” in accordance
with 18 USC section 1734 solely to indicate this fact. The opinions expressed in
this publication are those of the authors and are not attributable to the sponsors
or the publisher, Editor, or Editorial Board of The Journal of Nutrition.
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manuscript. All authors received travel funding to attend the workshop.
3 Author disclosures: J. D. Fernstrom is a scientific consultant to the Ajinomoto
Company. Research in S. D. Munger’s laboratory is funded by the NIH/National
Institute on Deafness and Other Communication Disorders (DC005633,
DC010110) and by Tate and Lyle Americas, LLC. S. D. Munger has previously
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advances provide important insights into how we interact with
sweeteners.
The gustatory system recognizes chemical stimuli that elicit
1 of 5 distinct perceptual qualities: sweet, sour, salty, bitter, and
umami (the savory taste of glutamate) (1). Stimulus detection
occurs through specialized taste cells, clustered together in small
groups (taste buds) found predominantly on the dorsal surface of
the tongue and soft palate. Activation of these cells by taste
stimuli releases neurotransmitters onto afferent cranial nerve
fibers, causing transmission of taste information to the brain.
The brain then processes this taste information, along with other
sensory information (including olfactory, thermal, and textural),
to elicit the perception of flavor and in the context of experience,
motivation, preference, and hedonic valence to promote an
appropriate ingestive response.
Individual taste cells express only one of several taste
receptor types (1). Taste receptors are responsible for initial
stimulus detection and selectivity. Type 1 taste receptor (T1R)
and T2R are members of the large family of G protein-coupled
receptors (2–4). T1R are heterodimers; the umami receptor is
composed of the T1R1 and T1R3 subunits (5,6), whereas the
sweet receptor contains T1R2 and T1R3 (6,7). The larger family
of T2R (25 genes in humans) recognizes many diverse com-
pounds that taste bitter (8,9). Most salty and sour-tasting stimuli
are detected by ion channels (10). However, with the exception
of the sodium-specific epithelial sodium channel (11), the
molecular identities of these channels remain unknown.
All compounds that elicit a sweet taste bind to and activate
the T1R2+T1R3 receptor. However, not all sweeteners bind to
the same sites on the receptor (Fig. 1). The sweet taste receptor
contains several binding sites for sweeteners and sweet taste
inhibitors (12). Each T1R subunit is composed of 3 principal
domains: an extracellular venus-flytrap (VFT) domain at the N
terminus, a seven transmembrane-spanning domain at the C
terminus, and a cysteine-rich linker joining them (12). Natural
and artificial sugars (e.g., sucrose, glucose, and sucralose) bind
to the VFT domains of both T1R2 and T1R3 (13), whereas
dipeptide sweeteners (e.g., aspartame and neotame) bind only to
the T1R2 VFT domain (14). The cyclamate binding pocket lies
within the seven transmembrane-spanning domain of T1R3
(14,15) and closely overlaps the binding site for the sweet taste
inhibitor lactisole (14,16). Sweet proteins such as thaumatin and
monellin interact across a larger binding surface that can include
both subunits and the cysteine-rich linkers (12). Incredibly, each
of these distinct sweetener-binding events leads to receptor
activation; if they did not, there would be no accompanying
perception of sweetness.
Genetic variation in the T1R genes explains many observed
differences in the ability to detect sweeteners across and within
species. For example, whereas humans find aspartame to be
sweet, rodents are indifferent to it (17). This species disparity in
the ability to taste aspartame results from small differences in the
gene encoding T1R2 (14). Indeed, a chimeric rodent sweet taste
receptor incorporating the human variant of the T1R2 VFT
domain is responsive to aspartame, whereas the fully rodent
receptor is not (14). Even single amino acid changes can affect
the ability of the sweet taste receptor to bind its ligand; a
common variant found in some mouse strains (18) markedly
reduces the affinity of the T1R3 subunit for sugars (13). Genetic
differences also affect sweetener side-tastes. For example,
certain variants of 2 T2R bitter receptors respond to saccharin
(19), providing a molecular explanation for the observation that
some people find that saccharin tastes both sweet and bitter.
Although ligand selectivity of the sweet taste receptor dictates
which compounds elicit sweet taste, the taste cell type deter-
mines the taste quality elicited (20). A particularly illustrative
experiment expressed the human T2R16 receptor, which is
responsive to the compound phenyl-b-D-glucopyranoside, in 2
different populations of mouse taste cells: one that normally
expresses T2R (“bitter” cells) and one that normally expresses
T1R2 and T1R3 (“sweet” cells) (21). Mice do not have a
functional T2R16 ortholog and are indifferent to the taste of
phenyl-b-D-glucopyranoside, which humans find bitter. As
predicted, humanizing the mouse by expressing T2R16 in
“bitter” cells resulted in a mouse that found the taste of
phenyl-b-D-glucopyranoside to be aversive (i.e., bitter). How-
ever, mice in which T2R16 was transgenically expressed in the
“sweet” cells found phenyl-b-D-glucopyranoside quite appeti-
tive. Therefore, T1R2+T1R3 determines what is sweet but not
why it is sweet.
Although T1R were first identified in the mouth and they
function in taste, it is now known that these receptors are
expressed throughout the body. Of note is the observation that
both T1R2 and T1R3 are expressed in endocrine cells of the
FIGURE 1 T1R2 and T1R3 and
the compounds that can activate
them. Font colors indicate sweet
compounds that bind T1R2 (red),
T1R3 (blue), or both subunits (pur-
ple). Modified from Vigues et al.
(12) with permission. T1R, type
1 taste receptor.
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gastrointestinal tract, where they may contribute to luminal glucose
sensing, the release of satiety hormones such as glucagon-like
peptide-1 (GLP-1), the expression of glucose transporters, and the
maintenance of glucose homeostasis (22–24). The potential role of
T1R in the assimilation of and postingestive response to sugars
in the digestive system highlights an interesting parallel in the
mouth, where receptors for a number of peptide hormones (e.g.,
GLP-1, glucagon, cholecystokinin, leptin) are expressed by taste
cells, often with their cognate ligands (25). Although the
contributions of these mechanisms remain somewhat unclear,
many may act to modulate sweet taste (26–28). Such studies
suggest that the efficacy of sweetener detection may be
modulated in the context of metabolic signals.
What Animal Models of Conditioning
Tell Us
Animal models have been extensively used to study energy and
LCS preferences, flavor conditioning, and the impact of sweet-
eners on energy intake and body weight. The rat and mouse are
the most commonly studied species because of their wide use in
nutritional and behavioral research and their well-characterized
“sweet tooth.” The availability of inbred and selected strains
that vary in their sweet taste sensitivity or predisposition to diet-
induced obesity is another major advantage of rodent models.
The limitations of rodents as models for human sweetener
research must be recognized. Rodents differ from humans in
their preferences for specific sweeteners. For example, whereas
humans report fructose as tasting sweeter than sucrose at
equienergy concentrations, rats andmice seem to taste sucrose as
the sweeter sugar (29). Rodents are also more limited than
humans in their attraction to LCS. Unlike humans, rats and mice
do not prefer the taste of aspartame and many rats avoid, rather
than prefer, sucralose (17,30,31).
The most commonly used LCS in rodent experiments is
saccharin, which at best is a weak surrogate for sucrose (32). The
most optimal saccharin solutions (0.2–0.4%) for rats are
preferred in comparison only to dilute sucrose solutions (2–
4%). The bitter aftertaste of saccharin may limit its palatability,
but it also seems that saccharin is simply not as sweet to rats as
concentrated sugar solutions (33). The current lack of a LCS that
matches the palatability of concentrated sugar solutions ($10%
sucrose) limits the ability to use rats to model human consump-
tion patterns of sugar and diet drinks.
Although rodents show a more restricted preference to LCS
compared with humans, they exhibit a more expansive preference
for carbohydrates in general. Unlike humans, rats andmice are very
attracted to starch and starch-derived maltodextrins and seem to
“taste” them as distinct from sugars (34). The rodent taste
sensitivity to starch and maltodextrin has important implications
for the interpretation of studies in which these carbohydrates are
used to discretely vary the energy density of foodswithout changing
their taste. In addition, the maltodextrin taste preference of rodents
can determine their preference for commercial sweetener products.
For example, rats that avoided sucralose solutions displayed strong
preferences for solutions containing Splenda (McNeil Nutritionals),
which is a blend of sucralose and maltodextrin (35).
Post-oral sugar conditioning. The palatability of sugar is
determined not only by its sweet taste but also by its post-oral
nutritive effects. This is demonstrated by the conditioned
preference and increased acceptance that rodents develop for
flavored solutions that are paired with i.g. sugar infusions (36).
Although sweet taste receptors (T1R2+T1R3) are found in the
gut (37), they do not mediate this post-oral action of sugars. This
is indicated by the finding that genetically modified mice missing
the T1R3 receptor subunit are similar to normal mice in their
flavor conditioning response to i.g. sucrose infusions (38). In
addition, i.g. infusion of the LCS sucralose, which activates gut
sweet receptors, does not condition a flavor preference (38).
Other findings indicate that glucose-specific sensors mediate
sugar conditioning and do so partly by activating the brain
dopamine (DA) reward system (39–41).
Humans also develop preferences for flavored foods or drinks
that are associated with post-oral sugar effects (42). In a 2010
study, humans increased their liking, compared with partici-
pants given placebo capsules, for novel unsweetened teas after
they ingested glucose capsules (43). In addition to activating
post-oral nutrient sensors linked to brain reward systems, sugars
in the gut generate negative feedback signals that lead to meal
termination (satiation) and delay subsequent feeding (satiety).
These negative feedback signals also serve as unconditioned
stimuli that become associated with flavor cues. Animals use
these flavor cues to predict the energy content of food (condi-
tioned satiety) and adjust meal size. Conditioned satiety has
been studied by training rats to consume low- and high-energy
foods labeled with distinctive flavor cues and testing their intake
response to the different flavors when presented in a food of
intermediate energy density (44). Sham-drinking studies, in
which rats with an open or closed gastric cannula are trained to
drink concentrated sugar solutions, have demonstrated that
sweet taste can serve as a conditioned satiety cue (45).
In contrast to concentrated sugar solutions, the taste of LCS
is not associated with potent satiety signals. It has been
hypothesized, therefore, that animals consuming both sugars
and LCS would learn that sweet taste does not reliably predict
energy content and become relatively insensitive to the satiating
effects of sweet foods (46). Some supporting evidence was
obtained in rats offered foods or drinks sweetened with
saccharin or glucose. A provocative extension of this hypothesis
suggests that the widespread availability of sweetened, low-
energy foods in the human diet may promote, rather than retard,
overeating and obesity by conditioning people to disregard
sweet taste as a predictor of energy content. In fact, the effect of
LCS on appetite and food intake is a subject of considerable
discussion (47). Nevertheless, results obtained with rats fed
saccharin- and sugar-sweetened foods must be interpreted with
caution. Saccharin is a poor sugar substitute for rats and may
only match the sweetness of diluted sugar solutions. If this is the
case, then rats may learn that sweet taste intensity predicts
energy density; slightly sweet foods are low in energy, whereas
sweeter foods are energy dense. It is important, therefore, to
match the sweetness level of low- and high-energy foods in
rodent studies investigating the role of learning in energy
regulation and dysregulation. This may not be possible in rats
given saccharin or other common LCS. Alternative methods are
available, such as training animals to real- and sham-drink sugar
solutions to break the association between sweet taste and post-
oral nutrition. Although it is more demanding, this procedure
may more closely match the human situation in which equally
sweet low- and high-energy foods and drinks are consumed.
The Neuroscience of Sweet Taste
The gustatory system allows the brain to monitor the presence of
chemicals in the mouth and initiate appropriate acceptance or
rejection responses. A sensory system has thus evolved in which
1136S Supplement
membrane receptors convey information on the presence of
metabolic fuels in the mouth to brain circuits controlling the
initiation of ingestive behaviors. However, the formation of
long-term sugar preferences does not exclusively rely on
sweetness perception but also requires reinforcing postingestive
effects. How does the brain control sugar intake in such a way
that previous associations between sensory properties and
postingestive effects become a regulating factor during nutrient
choice? One possibility is that a brain circuit exists in which
sensory and metabolic information converges through indepen-
dent pathways. Indeed, the midbrain DA system seems to be one
such candidate circuit.
The peripheral gustatory system provides the anatomic link
between the oral sensory epithelium and the motivational
circuits of the brain. As noted, sweet taste signaling is mediated
by T1R2+T1R3 receptors and associated intracellular effectors,
including phospholipase Cb2 and transient receptor potential
M5 taste channel (TRPM5). Deletion of either of these effectors
induces severe impairments in, if not taste blindness for, sweet,
umami, and bitter taste transduction (48).
Upon T1R2+T1R3, phospholipase Cb2, and TRPM5 acti-
vation, and ensuing taste cell depolarization and neurotrans-
mitter release, neural afferents of cranial nerves convey
gustatory information to the rostral division of the rostral
division of the nucleus tractus solitarius (rNTS) of the medulla
(49). In rodents, axonal fibers originating in rNTS ascend
ipsilaterally to the parabrachial nucleus (PBN), establishing this
pontine structure as the second-order gustatory relay (Fig. 2)
(50). From the PBN, a dorsal pathway projects to the
parvicellular part of the ventroposteromedial nucleus of the
thalamus (VPMpc, the taste thalamic nucleus) and a ventral
pathway to the amygdalar and lateral hypothalamic areas.
Thalamic afferents then project to the primary gustatory cortex,
which is defined as the VPMpc cortical target located within the
insular cortex. The primate counterpart has been established
with the notable exception that rNTS projections seem to bypass
PBN and proceed directly to VPMpc (51). Gustatory responses
to sugar sweetness have been amply demonstrated in the insular
and overlaying opercular cortices of monkeys using electro-
physiological methods (52,53) and in humans using functional
neuroimaging (54,55). Moreover, responses to sugars in the
orbitofrontal cortex (an insular target accordingly denominated
“secondary taste cortex”) seem to depend primarily on their
perceived pleasantness (55), including those situations in which
changes in motivational value derive from satiation (56). In
contrast, responses to sugars in amygdalar regions have been
associated instead with perceived stimulus intensity (55). How-
ever, it was recently proposed that the human amygdala may be
specifically sensitive to the energy content of sweet compounds,
as it seems to be preferentially responsive to beverages sweet-
ened with LCS compared with sugars (57).
Among the neurotransmitter systems known to be involved in
regulating the ingestion of sugars, a preponderant role has been
assigned to central DA systems. DA antagonists attenuate the
hedonic value of sweet-tasting nutrients; animals pretreated with
either D1 or D2 DA receptor antagonists behave toward high-
concentration sucrose solutions as if they were weaker than
usual (58–61). Conversely, tasting palatable foods elevates DA
levels in the nucleus accumbens (NAcc) of the ventral striatum
(62), a brain region implicated in food reinforcement (63). Taste-
elicited stimulation of DA systems seems to take place even in
the absence of intestinal nutrient absorption. In sham-feeding
studies in which a cannula is implanted in the stomach wall to
prevent nutrients from reaching the intestinal tract, NAcc DA
FIGURE 2 Neuroanatomy of the rodent taste pathways. Taste buds in the mouth are innervated by afferent (chorda tympani, greater
superficial petrosal, and glossopharyngeal) cranial nerves. Taste signals are conveyed to the nucleus of the solitary tract (NST) in the medulla and
from the NST to the taste portion of the PBN in rodents but seemingly not in primates. From the PBN, parallel projections reach the VPM of the
thalamus and forebrain limbic areas, including the amygdala and hypothalamus (not shown). Taste VPM projections define the gustatory aspect
of the cortex within the insula, from which taste information is conveyed to higher order regions, including the orbital cortex. Reproduced from
Yarmolinsky et al. (1) with permission. NST, nucleus of the solitary tract; PBN, parabrachial nucleus; VPM, ventral posterior medial thalamic
nucleus.
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levels increase in proportion to the concentration of the sucrose
solution used to stimulate the intraoral cavity (64).
In summary, the perceived sweetness associated with sugar
ingestion seems to act as a strong inducer of feeding and elicits
responses in reward-related brain areas. However, is sweetness
perception necessary for animals to develop a behavioral
attraction to sugar? One way to address this question involves
genetically engineered animals lacking functional taste trans-
duction. De Araujo et al. (41) recently designed a conditioning
protocol in which normal and Trpm5 knockout mice were
allowed to form nutrient-specific preferences for sipper locations
previously associated with a specific substance. The notion was
that sweet-blind Trpm5 knockout mice would develop a
preference for spouts associated with sucrose solutions when
allowed to detect the solutions’ rewarding postingestive effects.
In fact, during conditioning sessions, both wild-type and sweet-
indifferent Trpm5 knockout mice consumed significantly larger
amounts of sucrose than water. In addition, during postcondi-
tioning (water vs. water) 2-bottle tests, both wild-type and
knockout animals consumed during conditioning sessions
significantly more water from the sipper that contained nutritive
sweeteners. When the same experiments were run using the LCS
sucralose, unlike the case with sucrose, only wild-type animals
consumed more sucralose than water during the conditioning
sessions. Furthermore, during the 2-bottle test sessions, knock-
out mice, like their wild-type counterparts, showed no prefer-
ences for sippers associated with the delivery of sucralose.
Overall, these results provide evidence favoring the hypothesis
that postingestive effects exert positive control on ingestive
(licking/swallowing) behaviors even in the absence of taste
signaling or detection of distinct flavors.
Consistent with these findings, sugar intake by Trpm5 knock-
out mice, which cannot taste sweetness, increased extracellular
DA levels in the NAcc (41). Moreover, sucralose produced
significantly higher increases in DA levels in wild-type compared
with knockout animals. However, when the same comparison
was made for sucrose, no differences were found between the DA
release levels in wild-type and knockout mice, i.e., sucralose
produced significant DA stimulation only in wild-type mice,
whereas sucrose evoked the same DA increase in both wild-type
and knockout mice. Consistent with the above, rats given a local
NAcc infusion of a DA-1 receptor antagonist did not learn a
preference for a flavor paired with i.g. infusions of glucose (65).
These results therefore strongly suggest that even in the absence of
taste transduction and/or palatability, nutrient intake has the
ability to induce measurable tonic increases in NAcc DA.
By what mechanism might DA neurons sense changes in
nutritional state? Ren et al. (66) examined whether midbrain DA
neurons are influenced by glucose utilization rate in the body.
The hypothesis originated from the observations that: 1) Trpm5
knockout mice, although insensitive to both the taste of sugars
and sweet L-amino acids, displayed a greater preference for
glucose over the nongluconeogenic (but isoenergetic) amino acid
L-serine (66); 2) this higher preference for (and intake of)
glucose was associated with a higher glucose oxidation rate; and
3) the mice increased glucose intake after direct inhibition of
glucose oxidation [using i.v. 2-deoxyglucose (2-DG)] (67,66).
Wild-type mice were fitted with a striatal microdialysis probe
and a jugular venous catheter. Striatal DA release was monitored
after i.v. 2-DG infusion followed by glucose infusion. The notion
was that if glucose metabolism drives the rise in striatal DA
release following glucose ingestion, then 2-DG infusion should
reduce it. Thus, any inhibitory effect of 2-DG on DA release
should be reversed or attenuated by subsequent glucose infusion
(to restore glucose oxidation). I.v. infusion of 2-DG reduced
extracellular striatal DA levels and subsequent glucose infusion
partially reversed this effect. Importantly, glucose infusion
produced a robust increase in striatal DA compared with that
observed after 2-DG infusion (66). Therefore, glucose provision
following inhibition of glucose utilization elicits a stronger
relative increase in DA release than that observed when glucose
utilization is not inhibited (66–68).
The above findings suggest 2 tentative conclusions. First,
sweet-indifferent mice can develop nutrient-specific preferences
based solely on physiological (nontaste) cues. Second, brain DA
systems act as metabolic sensors responding to glucose oxidation
rates. More generally, sugar-specific behavioral preferences and
DA release may operate independently of sweetness and may be
regulated by glucose oxidation rates. Such regulation most likely
operates in addition to preabsorptive signals (37) that may
influence DA release during flavor-nutrient conditioning.
LCS, Gastrointestinal Sweet Receptors,
and Glucose Homeostasis: Are LCS
Nutritionally Active?
As noted above, major advances have been made in character-
izing taste receptors over the past decade. The sweet taste
receptor and many downstream signaling molecules that trans-
duce taste stimuli have been defined (1,12). The idea that a
process similar to taste might be involved in nutrient sensing in
the intestines was advanced several decades ago (69). Subse-
quently, the taste-related G protein a-gustducin was identified in
rat gut (37) and the expression of T1R family receptors was then
demonstrated in the intestines and enteroendocrine cells (22,70).
These receptors have been suggested to function in the luminal
sensing of sugars as well as in glucose absorption and metab-
olism (22,23,71). T1R are expressed in gut enteroendocrine cells
(e.g., L-cells and K-cells) and promote the release of the GLP-
1 and glucose-dependent insulinotropic polypeptide (GIP) from
enteroendocrine L cell lines (22) or duodenal explants (72).
These peptides stimulate the synthesis of sugar transport
proteins in enterocytes, thus facilitating the absorption of sugars
and ultimately their entry into the circulation (71). GLP-1 and/
or GIP also act on the pancreas to enhance insulin and reduce
glucagon secretion as well as modulate gastric emptying, gut
motility, and food intake (appetite reduction) (73). Thus, one
role of sweet taste receptors in enteroendocrine cells may be to
bind sugars when they are present in the alimentary canal,
facilitating their transfer across the gut lumen into the circula-
tion and ultimately into the cells in the body that use them to
generate energy.
Because LCS also interact with sweet taste receptors, might
they produce effects on the intestinal cells that express them? If
so, might LCS then elicit responses typically seen with sugars
(74), namely the release of incretins (e.g., GLP-1 and GIP)? If so,
LCS might disrupt glucose homeostasis by promoting glucose
uptake into tissues in the absence of ingested sugars and thereby
possibly lower blood sugar levels. The result might be to increase
appetite and food intake and/or disrupt glucose homeostasis,
thereby promoting increased incidence of obesity and/or meta-
bolic syndrome (74). Although this chain of events has not been
directly tested, many findings, especially in human participants,
suggest that it is unlikely to occur.
First, LCS ingestion by humans and animals does not cause
the hypothesized changes in blood glucose or hormone levels.
For example, rats given acesulfame-K, saccharin, stevia, or
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sucralose by gavage showed no change in blood concentrations
of GLP-1, GIP, and glucose (75). LCS gavage also did not
influence the rise in blood glucose during an oral glucose
tolerance test (75). In healthy humans, the ingestion of sucrose,
but not acesulfame-K, aspartame, cyclamate, or saccharin (at
moderate doses), increased blood glucose and insulin over a 2-h
period (76). Sucralose given orally to healthy individuals and
participants with diabetes at moderate and high doses did not
influence plasma C-peptide or glucose concentrations (C-peptide
is part of the proinsulin molecule; its blood level reflects recent
insulin secretion) (77) and did not alter the blood glucose
response to a large, oral glucose load (78). A single, oral, or i.g.
dose of sucralose (79,80), aspartame (80), or acesulfame-K (80)
also did not modify plasma concentrations of GLP-1 and peptide
YY (peptide YY is also secreted by L-cells and reduces hunger).
Furthermore, the chronic ingestion of sucralose by participants
with diabetes did not affect fasting plasma levels of glucose,
hemoglobin A1c (an indicator of blood glucose levels over time),
and C-peptide (81). A similar absence of effects was also
observed when the LCS rebaudioside A was consumed chron-
ically by patients with diabetes (82). Addressing one aspect of
metabolic syndrome, blood pressure was unchanged in healthy
participants following chronic oral ingestion of rebaudioside A
(83). Negative effects were also observed when the mouth was
bypassed; the i.g. infusion of sucrose, but not saline or sucralose,
in humans increased plasma concentrations of glucose, GLP-1,
GIP, and insulin and slowed gastric emptying (a known action of
GLP-1) (84,85). Finally, the intraduodenal infusion of glucose
increased plasma concentrations of glucose, GLP-1, insulin, and
glucose transport across the gut wall; again, sucralose infusion
was without effect (86).
Second, LCS ingestion does not increase food intake or body
weight. The most convincing effects have been seen chronically
in human studies in which LCS have been substituted covertly
for energy-containing sweeteners, using either aspartame
(87,88) or a blend of LCS (89) in typical foods. In general,
such studies show that the use of LCS reduces energy intake over
a period of weeks and can produce modest weight reduction.
Covert LCS substitution for energy-containing sweeteners in the
diet is appealing in the present context in which the LCS have
been hypothesized to promote weight gain by biochemical and
endocrine actions. Clearly, they do not. Studies in animals also
indicate that the very long-term ingestion of moderate to high
doses of LCS in food is not associated with increased food intake
or body weight gain (90–93).
In summary, although the presence of sweet taste receptors
on gut enteroendocrine cells is likely to be physiologically
important, the biochemical, endocrinological, and behavioral
evidence presently available, most notably in humans, does not
support the hypothesis that LCS cause a biochemical-endocri-
nological-behavioral cascade, beginning with the stimulation of
sweet receptors in intestinal enteroendocrine cells, that increases
food intake and body weight.
Conclusions
The molecular structure of the sweet receptor in the mouth was
recently elucidated and was subsequently found to be present on
intestinal enteroendocrine cells. Sweet receptors in the mouth
function in the perception of sweet taste; stimulating them with
either nutritive sweeteners or LCS results in activation of neural
pathways to and within the brain that interpret and react
to sweet stimuli. Indeed, recent research has greatly increased
knowledge regarding such brain circuitry. Intestinal sweet
receptors may facilitate sugar uptake from the alimentary canal,
release into the circulation, and extraction by cells in the body
for use for energy production. Both nutritive sweeteners and
LCS bind to sweet receptors. LCS, by definition, activate sweet
taste receptors in the mouth (as do nutritive sweeteners) and also
bind to sweet receptors on intestinal cells and induce the release
of hormones in some experimental models. However, the extent
to which LCS induce paracrine/endocrine signaling in vivo is
presently unresolved, particularly because human studies do not
show evidence of such effects or their postulated sequelae. It is
hoped that future studies will resolve this disparity. Some such
disparities may derive from differences in rodent and human
physiology. Although rodents have proven to be an excellent
model system for understanding the molecular basis of sweet
taste, rodents and humans differ in their perception of both
nutritive sweeteners and LCS. We hope that future studies will
expand the knowledge base regarding differences in sweet taste
perception across species to aid in understanding when animal
findings are or are not predictive of the human condition.
Much has thus been learned in recent years regarding the
biochemistry and physiology of sweet taste, yet much remains
to be revealed.
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